Enterovirus monoclonal antibodies, 6/14
June 2014—ViroStat released a pan-reactive monoclonal antibody that is positive for all 27 enteroviruses tested to date.
Webinars and Sponsored Roundtables — Register Now
Tuesday, October 20, 2026, 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.
Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Roche.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace
Next-generation blood gas analyzer, 6/14
May 2014—The Stat Profile Prime is a blood gas analyzer from Nova Biomedical. It combines the company’s MicroSensor Card with its Zero maintenance cartridge technology, which consists of individual cartridges for biosensors, calibrators, and liquid quality control.
Reusable sharps container, 5/14
December 2013—Rehrig Pacific’s SharpsTank reusable sharps container model TS has received FDA 510(k) clearance as a class II medical device. The SharpsTank model TS is a 4.9-gallon reusable container with an integrated hinged lid, restrictive mail chute, and flusher insert. The container is supplied to the customer fully assembled.
Clarient adopts THxID-BRAF, 5/14
April 2014—BioMérieux’s molecular diagnostic test THxID-BRAF has been added to the offerings provided by Clarient, a GE Healthcare company.
ConfirmMDx case study, 5/14
May 2014—Cancer test was used as part of a multidisciplinary approach to confirm prostate cancer diagnosis using a technique called transperineal mapping biopsy. The cancer lesions found using this method were not detected by five conventional biopsies.
Multilabel slide scanner, 5/14
May 2014—PerkinElmer launched the Lamina multilabel slide scanner at the USCAP 2014 Annual Meeting. The scanner is a high-throughput imaging system for research pathologists in a larger research facility to study protein expression and the relationships between disease markers in formalin-fixed, paraffin-embedded tissue sections.
Siemens, NKF enter strategic alliance, 5/14
May 2014—Siemens Healthcare and the National Kidney Foundation entered into a strategic alliance to increase awareness of the importance of albumin-to-creatinine ratio testing in high-risk individuals, with the goal of improving diagnosis and identifying kidney disease early in its course. Siemens and NKF will also help put the new clinical recommendations into practice.
Lynch syndrome diagnostic tests, 5/14
May 2014—Quest Diagnostics is offering new pathology and blood tests for identifying and assessing an individual’s risk of Lynch syndrome.
Bone marrow tissue stain, 5/14
May 2014—Dako added the Jenner-Wright Giemsa stain to its Artisan Link portfolio of automated stains. The stain is designed to provide clear differentiation and detail of the hematopoietic cells in bone marrow tissue samples for the diagnosis of cancer, aplastic anemia, and myelofibrosis.
Hsp70 ELISA kit, 5/14
May 2014—Enzo Life Sciences now offers the Amp’d HSP70 High Sensitivity ELISA Kit for detecting both baseline and upregulated levels of Hsp70 (Hsp72).